GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Deferred Tax

GeneOne Life Science (XKRX:011000) Deferred Tax : ₩113 Mil (TTM As of Dec. 2023)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Deferred Tax?

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

GeneOne Life Science's change in deferred tax for the three months ended in Dec. 2023 was ₩100 Mil. Its change in deferred tax for the trailing twelve months (TTM) ended in Dec. 2023 was ₩113 Mil.

GeneOne Life Science Deferred Tax Historical Data

The historical data trend for GeneOne Life Science's Deferred Tax can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Deferred Tax Chart

GeneOne Life Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Deferred Tax
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 353.75 95.79 113.45

GeneOne Life Science Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Deferred Tax Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.86 12.80 0.20 0.05 100.40

GeneOne Life Science Deferred Tax Calculation

Change In Deferred Tax represents future tax liability or asset, resulting from temporary differences between book (accounting) value of assets and liabilities, and their tax value. This arises due to differences between financial accounting for shareholders and tax accounting.

Deferred Tax for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩113 Mil.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GeneOne Life Science Deferred Tax Related Terms

Thank you for viewing the detailed overview of GeneOne Life Science's Deferred Tax provided by GuruFocus.com. Please click on the following links to see related term pages.

GeneOne Life Science (XKRX:011000) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Deferred Tax
Comparable Companies
XKRX:053030 XKRX:048870 XKRX:060590 XKRX:397030 XKRX:115450 XKRX:083790 XKRX:048530 XKRX:086890 XKRX:278650 XKRX:199800 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
Website
http://www.genels.com
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science (XKRX:011000) Headlines

No Headlines